| Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations (NCT01983774) | Columbia University | 2008-02-01 |
| SD Cystic Fibrosis Study (NCT00605761) | GlaxoSmithKline | 2008-02-01 |
| Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease (NCT00625612) | Merck Sharp & Dohme LLC | 2008-02-01 |
| Time to Perform Lung Function Test in Cystic Fibrosis (NCT01737801) | Karolinska University Hospital | 2008-02-01 |
| Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa (NCT00558844) | Insmed Incorporated | 2008-01-01 |
| Effect of Pioglitazone on Inflammation in Cystic Fibrosis (NCT00719381) | Paul Beringer | 2008-01-01 |
| The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis (NCT00557089) | The Hospital for Sick Children | 2008-01-01 |
| Segmentation of Structural Abnormalities in Chronic Lung Diseases (NCT04760548) | Hôpital Haut Lévêque | 2008-01-01 |
| Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis (NCT00750932) | University Hospital, Tours | 2008-01-01 |
| Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation (NCT00788359) | University of Colorado, Denver | 2007-12-01 |
| Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (NCT00510484) | Solvay Pharmaceuticals | 2007-11-01 |
| Miglustat / OGT 918 in the Treatment of Cystic Fibrosis (NCT00537602) | Actelion | 2007-11-01 |
| Structure and Function of Salivary Proteins (NCT00916682) | Boston Children's Hospital | 2007-11-01 |
| Choline Nutrition in Children With Cystic Fibrosis (NCT01070446) | University of British Columbia | 2007-10-01 |
| Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis (NCT00528190) | Ottawa Hospital Research Institute | 2007-10-01 |
| Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs (NCT00590330) | Boston Children's Hospital | 2007-10-01 |
| Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents (NCT00758771) | University of California, San Francisco | 2007-10-01 |
| Absorptive Clearance in the Cystic Fibrosis Airway (NCT00541190) | University of Pittsburgh | 2007-10-01 |
| Choline Nutritional Status Of Children With Cystic Fibrosis X-Sectional Study (NCT01150136) | University of British Columbia | 2007-10-01 |
| Choline Nutrition in Children With Cystic Fibrosis (CF) (NCT00686361) | University of British Columbia | 2007-10-01 |
| Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis (NCT00577499) | University of Arkansas | 2007-10-01 |
| Coping Compliance and Adjustment in Adolescents With Cystic Fibrosis (NCT00577252) | Akron Children's Hospital | 2007-10-01 |
| Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis (NCT00671736) | AOP Orphan Pharmaceuticals AG | 2007-10-01 |
| Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis (NCT00534079) | University of Jena | 2007-09-01 |
| Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis (NCT00546663) | CF Therapeutics Development Network Coordinating Center | 2007-09-01 |
| Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers (NCT00531882) | University Hospitals Cleveland Medical Center | 2007-09-01 |
| Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients (NCT00499837) | Kamada, Ltd. | 2007-09-01 |
| Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis (NCT00221546) | University Hospital, Ghent | 2007-09-01 |
| Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis (NCT01018303) | University of Colorado, Denver | 2007-08-01 |
| Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease (NCT00425165) | Merck Sharp & Dohme LLC | 2007-08-01 |
| Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis Patients (NCT00506688) | Mukoviszidose Institut gGmbH | 2007-07-01 |
| Sleep in Patients With Cystic Fibrosis (NCT00804661) | Assistance Publique - Hôpitaux de Paris | 2007-07-01 |
| Hypertonic Saline and Mucociliary Clearance in Children (NCT01293084) | Johns Hopkins University | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic Fibrosis (NCT00506792) | Novartis Pharmaceuticals | 2007-07-01 |
| Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI) (NCT00513682) | Forest Laboratories | 2007-07-01 |
| Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner (NCT00485082) | National Human Genome Research Institute (NHGRI) | 2007-06-05 |
| Open-Label Phase III Long-Term Safety Trial of Liprotamase (NCT00449904) | Anthera Pharmaceuticals | 2007-06-01 |
| Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis (NCT00503490) | Amgen | 2007-06-01 |
| Safety Study of Ivacaftor in Subjects With Cystic Fibrosis (NCT00457821) | Vertex Pharmaceuticals Incorporated | 2007-05-01 |
| Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency (NCT00449878) | Anthera Pharmaceuticals | 2007-05-01 |
| Do Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis? (NCT00716664) | Royal Brompton & Harefield NHS Foundation Trust | 2007-03-01 |
| Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study (NCT00446680) | Syntara | 2007-03-01 |
| Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People (NCT00418470) | University of Florence | 2007-03-01 |
| Exercise Training Study for Patients With Cystic Fibrosis (NCT00609050) | University of Pittsburgh | 2007-03-01 |
| A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC) (NCT00434278) | Genentech, Inc. | 2007-03-01 |
| Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™) (NCT00777296) | Insmed Incorporated | 2007-02-22 |
| Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa (NCT00431964) | CF Therapeutics Development Network Coordinating Center | 2007-02-01 |
| Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI (NCT00406536) | Avanti Polar Lipids, Inc. | 2007-01-01 |
| Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis (NCT00432861) | Digestive Care, Inc. | 2007-01-01 |
| Airway Clearance Using High Frequency Chest Wall Oscillation (NCT00817947) | Royal Brompton & Harefield NHS Foundation Trust | 2007-01-01 |
| Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis (NCT00721071) | The Hospital for Sick Children | 2006-12-01 |
| Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis (NCT00416182) | University of Vermont | 2006-12-01 |
| PTC124 for the Treatment of Cystic Fibrosis (NCT00351078) | PTC Therapeutics | 2006-12-01 |
| Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis (NCT00547053) | Boston Children's Hospital | 2006-12-01 |
| The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic Fibrosis (NCT00405665) | The Hospital for Sick Children | 2006-11-01 |
| Improving Vitamin D Status In Cystic Fibrosis (NCT00450073) | Atlanta VA Medical Center | 2006-11-01 |
| Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) (NCT00408317) | Forest Laboratories | 2006-11-01 |
| Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease (NCT00368446) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-10-17 |
| Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo (NCT00515229) | University Hospital Tuebingen | 2006-10-01 |
| Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic Fibrosis (NCT00391703) | University Hospital, Grenoble | 2006-10-01 |
| Evaluation of a Decision Aid for Adult Cystic Fibrosis Patients Considering Bilateral Lung Transplantation (NCT00345449) | Ottawa Hospital Research Institute | 2006-09-01 |
| Nasal Epithelial Cells/Blood Lymphocyte Markers for Cystic Fibrosis (CF)/CF Pulmonary Exacerbations (NCT00381628) | University Hospitals Cleveland Medical Center | 2006-09-01 |
| Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients (NCT02172534) | Boehringer Ingelheim | 2006-09-01 |
| Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea (NCT00572975) | Children's Hospital of Philadelphia | 2006-08-01 |
| 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF) (NCT00363402) | Hadassah Medical Organization | 2006-08-01 |
| Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease (NCT00357279) | Merck Sharp & Dohme LLC | 2006-07-01 |
| Capsule Endoscopy in Cystic Fibrosis (NCT00333957) | Hadassah Medical Organization | 2006-07-01 |
| Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis (NCT00458614) | Arkansas Children's Hospital Research Institute | 2006-06-01 |
| Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis (NCT00221572) | University Hospital, Ghent | 2006-06-01 |
| Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00297167) | Forest Laboratories | 2006-05-01 |
| Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar) (NCT00504361) | Weill Medical College of Cornell University | 2006-05-01 |
| Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT00981214) | Forest Laboratories | 2006-05-01 |
| Rare Genetic Disorders of the Breathing Airways (NCT00323167) | University of North Carolina, Chapel Hill | 2006-05-01 |
| Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study (NCT00399945) | Novartis | 2006-05-01 |
| Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease (NCT00322868) | University Hospitals Cleveland Medical Center | 2006-04-01 |
| Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study (NCT00420836) | Novartis | 2006-04-01 |
| Self Drainage in Pediatric Cystic Fibrosis Patients (NCT01509235) | Hospices Civils de Lyon | 2006-03-01 |
| Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis (NCT00753987) | The Hospital for Sick Children | 2006-03-01 |
| Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. (NCT00308243) | Emphycorp | 2006-03-01 |
| Antimicrobial Resistance in Cystic Fibrosis (CF) (NCT00360503) | Seattle Children's Hospital | 2006-03-01 |
| Hydroxychloroquine in Cystic Fibrosis (NCT00311883) | Vanderbilt University | 2006-03-01 |
| Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis (NCT00287443) | University of Texas Southwestern Medical Center | 2006-02-02 |
| One Year Glargine Treatment in CFRD Children and Adolescents (NCT00483769) | Federico II University | 2006-02-01 |
| Azithromycin in Patients With CF, Infected With Burkholderia Cepacia Complex (NCT00298922) | Unity Health Toronto | 2006-02-01 |
| Comparison of Airway Clearance Efficacy of Two High Frequency Chest Wall Oscillation (HFCWO) Devices in Cystic Fibrosis (NCT00308958) | University of Minnesota | 2006-02-01 |
| A Phase I Study of Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. (NCT00332215) | University of Minnesota | 2006-02-01 |
| Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis (NCT00287430) | University of Texas Southwestern Medical Center | 2006-01-01 |
| FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis (NCT00404859) | Maastricht University Medical Center | 2006-01-01 |
| Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients (NCT00274313) | Parion Sciences | 2006-01-01 |
| A Study of Home Monitoring in Adults With Cystic Fibrosis (HOMECF) (NCT02994706) | Heart of England NHS Trust | 2006-01-01 |
| Pre-flight Evaluation of Adult Patients With Cystic Fibrosis (NCT01569880) | Oslo University Hospital | 2006-01-01 |
| Behavioral & Nutritional Treatment to Help CF Preschoolers Grow (NCT00241969) | Children's Hospital Medical Center, Cincinnati | 2006-01-01 |
| Cystic Fibrosis and Totally Implantable Vascular Access Devices (NCT00244270) | Assistance Publique - Hôpitaux de Paris | 2005-12-01 |
| Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis (NCT00265434) | University of Jena | 2005-12-01 |
| Prevalence of Chronic Rhinosinusitis in Cystic Fibrosis (NCT00266474) | University of Jena | 2005-12-01 |
| Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis (NCT00237380) | PTC Therapeutics | 2005-11-30 |
| Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway (NCT00248755) | University of Pittsburgh | 2005-11-01 |
| Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis (NCT00117208) | Syntara | 2005-11-01 |
| Mannitol Dose Response Study in Cystic Fibrosis (NCT00251056) | Syntara | 2005-10-01 |
| Blood Collection From Individuals With Lung Disease for Genetic Studies (NCT00362739) | Weill Medical College of Cornell University | 2005-09-01 |